rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-3-29
|
pubmed:abstractText |
(i) To generate a new heterodinucleotide (3TCpPMPA) comprising the drugs lamivudine and tenofovir which have been shown to act synergistically and (ii) to protect macrophages from 'de novo' HIV-1-infection through its administration.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0305-7453
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
666-75
|
pubmed:meshHeading |
pubmed-meshheading:17327293-Adenine,
pubmed-meshheading:17327293-Animals,
pubmed-meshheading:17327293-Anti-HIV Agents,
pubmed-meshheading:17327293-Chromatography, High Pressure Liquid,
pubmed-meshheading:17327293-Culture Media,
pubmed-meshheading:17327293-Erythrocytes,
pubmed-meshheading:17327293-Female,
pubmed-meshheading:17327293-HIV-1,
pubmed-meshheading:17327293-Humans,
pubmed-meshheading:17327293-Indicators and Reagents,
pubmed-meshheading:17327293-Lamivudine,
pubmed-meshheading:17327293-Macrophages,
pubmed-meshheading:17327293-Mice,
pubmed-meshheading:17327293-Phosphonic Acids,
pubmed-meshheading:17327293-Reverse Transcriptase Inhibitors,
pubmed-meshheading:17327293-Virus Replication
|
pubmed:year |
2007
|
pubmed:articleTitle |
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
|
pubmed:affiliation |
Institute of Biochemistry G. Fornaini, University of Urbino Carlo Bo, 61029 Urbino, Italy. l.rossi@uniurb.it
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|